TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2/27/24 13:47 | 2/23/24 | PFE | Pfizer Inc | DE | Health | Drug | Pharmaceutical Preparations | McDermott Michael | NY | O | EVP | M.d | 339 | 27.34 | 0 | 12 | 20 | 75 | D | ||||||||||||||
2/28/23 17:52 | 2/25/23 | PFE | Pfizer Inc | DE | Health | Drug | Pharmaceutical Preparations | McDermott Michael | NY | O | EVP | M.d | 325 | 22.89 | 0 | 14 | 21 | 81 | D | ||||||||||||||
2/24/23 20:52 | 2/22/23 | PFE | Pfizer Inc | DE | Health | Drug | Pharmaceutical Preparations | McDermott Michael | NY | O | EVP | M.d | 401 | 30.17 | 0 | 13 | 20 | 79 | D | ||||||||||||||
3/1/22 16:03 | 2/26/22 | PFE | Pfizer Inc | DE | Health | Drug | Pharmaceutical Preparations | McDermott Michael | NY | O | EVP | M.d | 316 | 25.60 | 0 | 12 | 20 | 74 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |